SYNVISC
FDA premarket approval P940015/S038 · decided 2017-01-18
Approval details
- PMA number
- P940015
- Supplement
- S038
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- SYNVISC
- Generic name
- Acid, hyaluronic, intraarticular
- Applicant
- Sanofi Genzyme Corp.
- Date received
- 2016-12-12
- Decision date
- 2017-01-18
- Days to decision
- 37 days
- Decision code
- OK30
- Product code
- MOZ
- Advisory committee
- Orthopedic
- Expedited review
- No
- Location
- Cambridge, MA
- Statement
- Reduction in the testing intervals for routine marketed product surveillance stability studies for Synvisc and Synvisc-One.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.